STAAR Surgical Company (STAA)

Gross profit margin

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Gross profit (ttm) US$ in thousands 252,651 241,711 238,535 231,681 223,383 218,589 203,428 188,759 178,637 167,947 157,517 132,744 118,362 112,885 107,065 112,534 111,954 106,122 100,931 96,259
Revenue (ttm) US$ in thousands 322,415 310,186 305,924 294,719 284,391 279,348 261,654 242,920 230,472 217,469 206,198 179,025 163,460 156,345 148,319 152,789 150,185 142,488 135,203 129,444
Gross profit margin 78.36% 77.92% 77.97% 78.61% 78.55% 78.25% 77.75% 77.70% 77.51% 77.23% 76.39% 74.15% 72.41% 72.20% 72.19% 73.65% 74.54% 74.48% 74.65% 74.36%

December 31, 2023 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $252,651K ÷ $322,415K
= 78.36%

STAAR Surgical Company's gross profit margin has shown a generally increasing trend over the past five quarters, from 74.36% in Q1 2019 to 78.36% in Q4 2023. This indicates that the company has been able to effectively manage its cost of goods sold and generate a higher proportion of revenue as gross profit. The year-over-year improvement in the gross profit margin reflects the company's ability to increase efficiency in production and pricing strategies, leading to stronger profitability. In particular, the significant increase from 72.41% in Q4 2021 to 78.36% in Q4 2023 suggests successful cost containment measures or pricing adjustments. Overall, the rising trend in the gross profit margin indicates a positive financial performance for STAAR Surgical Company in terms of generating profits from its core operations.


Peer comparison

Dec 31, 2023

Company name
Symbol
Gross profit margin
STAAR Surgical Company
STAA
78.36%
National Vision Holdings Inc
EYE
10.77%
The Cooper Companies Inc.
COO
68.12%